Potential effect of IL-4 and IL-13 (250 ng/mL, 24 h) on the expression of genes encoding proteins relevant for cancer development by facilitating angiogenesis (HIF1A and VEGFA), inflammation (PTGS2, NOS2, CCL2), and metabolic reprogramming (GLUT1, ODC1, NOS2) was evaluated. Here, SLC2A1 is linked to cancer.